No Data
No Data
Intel Group (000411.SZ): Normal business dealings with companies such as Eli Lilly and Novo Nordisk
GLONGHUI March 13 | Intel Group (000411.SZ) said on the investor interactive platform that the company is a pharmaceutical distribution company, mainly engaged in the wholesale and retail business of pharmaceuticals and medical devices, and has normal business dealings with companies such as Eli Lilly and Novo Nordisk.
Intel Group (000411.SZ): As of March 8, 2024, the number of shareholders of the company was 27,588
Gelonghui March 13 | Intel Group (000411.SZ) said on the investor interactive platform that as of February 29, 2024, the number of shareholders of the company was 27,145. As of March 8, 2024, the number of shareholders of the company was 27,588.
The pharmaceutical business sector fluctuated and picked up, and Intel Group went up and down
Gelonghui, March 8 | The A-share pharmaceutical business sector fluctuated and rose. Inter Group went up and down, Pharmaceuticals Ebuy rose more than 4%, and Liu Pharmaceutical Group, First Pharmaceutical, Yifeng Pharmacy, Chinese Health, etc. followed suit.
Intel Group (000411.SZ): As of January 31, 2024, the number of shareholders of the company was 27,853
Gelonghui, Feb. 7 | Intel Group (000411.SZ) said on the investor interactive platform that as of January 31, 2024, the number of shareholders of the company was 27,853.
Intel Group (000411.SZ): As of January 10, 2024, the number of shareholders of the company was 28,236
Gelonghui January 24 | Intel Group (000411.SZ) said on the investor interactive platform that as of January 10, 2024, the number of shareholders of the company was 28,236.
Express News | Intel Group: Net profit in 2023 is expected to increase 18.58% — 37.25% over the same period last year after the restructuring
No Data